MREO logo

Mereo BioPharma Group plc (MREO)

Profile

Full Name

Mereo BioPharma Group plc

Ticker

NASDAQ: MREO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

April 24, 2019

Indexes

Not included

Website

http://www.mereobiopharma.com

Employees

36

Key Details

Price

$1.74(+1.75%)

Market cap

$276.66M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.30(-50.00% YoY)

PE ratio

-

Next earnings date

Aug 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.74
    MREO price is $1.74

    30-Day Relative Volume

    0.36
    MREO 30-day relative volume is 0.36

    Price Performance

    Price Most recent change

    +1.75%
    MREO price was up +1.75% on Jul 30, 2025

    Price YTD change

    -50.29%
    MREO price is down -50.29% since January 1st

    Price 1-year change

    -56.39%
    MREO price is down -56.39% year-on-year

    Price 3-year change

    +43.8%
    MREO price is up +43.8% over the past 3 years

    Price Range

    Price All-time high

    $8.48
    MREO price is currently -79.48% below its historical high of $8.48

    Price 3-year low

    $0.49
    MREO price is currently +251.52% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $276.66M
    MREO market capitalization is $276.66 million

    Market cap 3-year change

    +95.82%
    MREO market capitalization is up +95.82% over the past 3 years

    Market cap All-time high

    $753.88M
    MREO market capitalization is currently -63.30% below its historical high of $753.88 million

    Market cap sector rank

    56.85%
    MREO market capitalization is higher than 56.85% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.41%
    MREO shares outstanding is up +3.41% year-on-year

    Shares Outstanding 3-Year Change

    +36.17%
    MREO shares outstanding is up +36.17% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.09
    MREO beta is 1.09

    200-day SMA

    $2.92
    MREO price is currently -40.44% below its 200-day simple moving average

    50-day SMA

    $2.35
    MREO price is currently -25.95% below its 50-day simple moving average

    RSI

    35.57
    MREO 14-day relative strength index is 35.57

    Volume

    0.36
    MREO 30-day relative volume is 0.36

    ATR

    $0.13
    MREO average true range is $0.13

    10-day Historical Volatility

    57.05%
    MREO 10-day historical volatility is 57.05%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    MREO annual revenue value is unknown

    Revenue Analysts estimate

    $17.88M
    MREO annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    MREO annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    MREO annual revenue is unknown

    EPS

    EPS

    -$0.30
    MREO annual earnings per share is -$0.30

    EPS Analysts estimate

    -$0.02
    MREO annual earnings per share is currently +1356.31% higher than the consensus analysts' forecast

    EPS 1-year change

    -50%
    MREO annual earnings per share is down -50% year-on-year

    EPS Sector rank

    72.9%
    MREO annual earnings per share is higher than 72.9% of companies in Healthcare sector

    Profit

    Gross profit

    $0.00
    MREO annual gross profit is $0.00

    Gross margin

    -
    MREO annual gross profit margin value is unknown

    Operating profit

    -$45.72M
    MREO annual operating income is -$45.72 million

    Operating margin

    -
    MREO annual operating profit margin value is unknown

    Net income

    -$43.25M
    MREO annual net profit is -$43.25 million

    Net margin

    -
    MREO annual net profit margin value is unknown

    Expenses

    Total expenses

    $45.72M
    MREO annual total expenses is $45.72 million

    Operating expenses

    $45.72M
    MREO annual total operating expenses is $45.72 million

    Cost of goods sold

    -
    MREO annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $26.43M
    MREO annual SGA is $26.43 million

    Depreciation and amortization

    $1.09M
    MREO annual depreciation & amortization is $1.09 million

    Interest expense

    $1.37M
    MREO annual interest expense is $1.37 million

    Income tax

    $0.00
    MREO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$41.88M
    MREO annual earnings before interest & taxes is -$41.88 million

    EBITDA

    -$40.80M
    MREO annual EBITDA is -$40.80 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $76.39M
    MREO annual total assets is $76.39 million

    Non current assets

    $1.63M
    MREO annual long term assets is $1.63 million

    Current assets

    $74.76M
    MREO annual total current assets is $74.76 million

    Cash and cash equivalents

    $69.80M
    MREO annual cash & cash equivalents is $69.80 million

    Accounts receivable

    -
    MREO annual accounts receivable value is unknown

    Inventory

    -
    MREO annual inventory value is unknown

    Liabilities

    Total liabilities

    $15.42M
    MREO annual total liabilities is $15.42 million

    Long term liabilities

    $1.57M
    MREO annual total long term liabilities is $1.57 million

    Current liabilities

    $13.85M
    MREO annual total current liabilities is $13.85 million

    Accounts payable

    $2.44M
    MREO annual accounts payable is $2.44 million

    Debt

    Total debt

    $6.43M
    MREO annual total debt is $6.43 million

    Total debt 1-year change

    +8.01%
    MREO annual total debt is up +8.01% year-on-year

    Long term debt

    $187.00K
    MREO annual long term debt is $187.00 thousand

    Short term debt

    $6.24M
    MREO annual short term debt is $6.24 million

    Equity & Capital

    Shareholders equity

    $60.97M
    MREO annual stockholders equity is $60.97 million

    Book value

    $60.97M
    MREO annual book value is $60.97 million

    Retained earnings

    -$462.88M
    MREO annual retained earnings is -$462.88 million

    Working capital

    $60.91M
    MREO annual working capital is $60.91 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$32.83M
    MREO annual cash flow from operations is -$32.83 million

    Cash from operations 1-year change

    -55.38%
    MREO annual cash flow from operations is down -55.38% year-on-year

    Cash from investing

    -$699.00K
    MREO annual cash flow from investing activities is -$699.00 thousand

    Cash from investing 1-year change

    -66.83%
    MREO annual cash flow from investing activities is down -66.83% year-on-year

    Cash from financing

    $46.15M
    MREO annual cash flow from financing activities is $46.15 million

    Cash from financing 1-year change

    +478.79%
    MREO annual cash flow from financing activities is up +478.79% year-on-year

    CAPEX

    CAPEX

    -
    MREO annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    MREO annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$33.53M
    MREO annual free cash flow is -$33.53 million

    Free cash flow 1-year change

    -55.6%
    MREO annual free cash flow is down -55.6% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    MREO annual gross profit margin value is unknown

    Operating margin

    -
    MREO annual operating profit margin value is unknown

    Net margin

    -
    MREO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -56.62%
    MREO annual return on assets is -56.62%

    ROE

    -70.94%
    MREO annual return on equity is -70.94%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    MREO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    MREO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    4.60
    MREO price to book ratio is 4.60

    PB ratio Sector rank

    78.06%
    MREO price to book ratio is higher than 78.06% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    MREO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    MREO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $214.92M
    MREO enterprise value is $214.92 million

    Enterprise value Sector rank

    54.55%
    MREO enterprise value is higher than 54.55% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -4.79
    MREO EV/EBITDA is -4.79

    EV/EBITDA Sector rank

    24.96%
    MREO EV/EBITDA is higher than 24.96% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.40
    MREO annual current ratio is 5.40

    Quick ratio

    -
    MREO annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.11
    MREO annual debt to equity ratio is 0.11

    Interest coverage ratio

    -30.57
    MREO annual interest coverage ratio is -30.57

    Risk & Stability

    Piotroski F-Score

    -
    MREO piotroski f-score value is unknown

    Altman Z-Score

    -
    MREO altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jul 10, 25 Needham
    Buy
    May 13, 25 Needham
    Buy
    Apr 9, 25 Needham
    Buy
    Mar 27, 25 JP Morgan
    Overweight
    Mar 26, 25 Needham
    Buy
    Mar 18, 25 Cantor Fitzgerald
    Overweight
    Jan 13, 25 Needham
    Buy
    Dec 24, 24 LifeSci Capital
    Outperform
    Dec 17, 24 Needham
    Buy
    Dec 6, 24 Jefferies
    Buy

    Institutional Ownership

    Screeners with MREO included

    Growing Shares Outstanding
    Stocks with high beta
    UK stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Mereo BioPharma Group plc?
    • Does Mereo BioPharma Group plc pay dividends?
    • What sector is Mereo BioPharma Group plc in?
    • What industry is Mereo BioPharma Group plc in?
    • What country is Mereo BioPharma Group plc based in?
    • When did Mereo BioPharma Group plc go public?
    • Is Mereo BioPharma Group plc in the S&P 500?
    • Is Mereo BioPharma Group plc in the NASDAQ 100?
    • Is Mereo BioPharma Group plc in the Dow Jones?
    • When was Mereo BioPharma Group plc's last earnings report?
    • When does Mereo BioPharma Group plc report earnings?

    What is the ticker symbol for Mereo BioPharma Group plc?

    The ticker symbol for Mereo BioPharma Group plc is NASDAQ:MREO

    Does Mereo BioPharma Group plc pay dividends?

    No, Mereo BioPharma Group plc does not pay dividends

    What sector is Mereo BioPharma Group plc in?

    Mereo BioPharma Group plc is in the Healthcare sector

    What industry is Mereo BioPharma Group plc in?

    Mereo BioPharma Group plc is in the Biotechnology industry

    What country is Mereo BioPharma Group plc based in?

    Mereo BioPharma Group plc is headquartered in United Kingdom

    When did Mereo BioPharma Group plc go public?

    Mereo BioPharma Group plc's initial public offering (IPO) was on April 24, 2019

    Is Mereo BioPharma Group plc in the S&P 500?

    No, Mereo BioPharma Group plc is not included in the S&P 500 index

    Is Mereo BioPharma Group plc in the NASDAQ 100?

    No, Mereo BioPharma Group plc is not included in the NASDAQ 100 index

    Is Mereo BioPharma Group plc in the Dow Jones?

    No, Mereo BioPharma Group plc is not included in the Dow Jones index

    When was Mereo BioPharma Group plc's last earnings report?

    Mereo BioPharma Group plc's most recent earnings report was on May 13, 2025

    When does Mereo BioPharma Group plc report earnings?

    The next expected earnings date for Mereo BioPharma Group plc is August 13, 2025
    On this page